Scientists reprogram Patients' own immune cells to hunt deadly brain cancer
NCT ID NCT03389230
First seen Feb 04, 2026 · Last updated Apr 13, 2026 · Updated 9 times
Summary
This early-stage study is testing a new type of personalized cell therapy for patients with aggressive brain tumors that have returned or stopped responding to standard treatments. Doctors collect a patient's own immune cells, genetically modify them in a lab to recognize and attack tumor cells, and then infuse them back into the brain. The main goals are to find the safest dose and understand the side effects of this experimental approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.